Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004533 · ClinicalTrials.gov registry record
The Development and Evaluation of a Novel Duodenoscope Assessment Tool
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 745
- Enrollment target
NCT04004533 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 745 participants.
The verdict
NCT04004533 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 745 participants
- Enrollment target
Study Summary
Endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed using duodenoscopes for the treatment of pancreatic and biliary diseases. Although outcomes in endoscopic retrograde cholangiopancreatography (ERCP) procedures are measured mainly in terms of procedural success and complications, currently there are no objective tools to assess the technical performance of the duodenoscopes. The Center for Interventional Endoscopy has maintained a multicenter database that prospectively evaluates the technical performance of duodenoscopes for performing ERCPs. Our objective is to analyze the database in order to summarize the technical performance of duodenoscopes during ERCPs and evaluate the reliability of the duodenoscope assessment tool.
Interventions
- PROCEDURE Endoscopic retrograde cholangiopancreatography (ERCP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 745 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04004533
The ClinicalTrials.gov registry entry for NCT04004533 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 745 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic retrograde cholangiopancreatography (ERCP) is the first listed.
NCT04004533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04004533 about?
NCT04004533 is a clinical study titled "The Development and Evaluation of a Novel Duodenoscope Assessment Tool". Endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed using duodenoscopes for the treatment of pancreatic and biliary diseases. Although outcomes in endoscopic retrograde cholangiopancreatography (ERCP) procedures are measured mainly in terms of procedural success and compli...
What is the current status of trial NCT04004533?
This trial is currently completed. The enrollment target is 745 participants. The study started on 2019-05-20. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04004533?
The interventions under investigation include: Endoscopic retrograde cholangiopancreatography (ERCP) (PROCEDURE).
Who is sponsoring clinical trial NCT04004533?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.